window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Biotech,Cell & Gene Therapy,Clinical Development,Drug discovery,Research & Development,Technology and platforms

    Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing

    Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

    April 24, 2026
  • Clinical Development,Clinical studies,Digital Health,FDA,Medical devices,Technology and platforms

    Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal

    Viz.ai has entered a collaboration with Johnson & Johnson to [...]

    April 22, 2026
  • CDMOs & Manufacturing,Drug discovery,Ingredients,Manufacturing,Sustainability,Technology and platforms

    Merck launches bio-based HPLC solvents for pharma labs

    Merck has launched a portfolio of bio-based solvents for high-performance [...]

    April 22, 2026
  • Drug Delivery & Formulation,Drug Development,Oncology,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development

    Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

    April 18, 2026
  • Biotech,Clinical Trials,Drug discovery,Funding,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline

    Neomorph has closed a $100 million Series B financing to [...]

    April 18, 2026
  • Drug discovery,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion

    Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

    April 18, 2026
  • Biotech,Drug discovery,Facilities and infrastructure,Research & Development,Technology and platforms

    FairJourney Bio opens cryo-EM facility in San Diego for antibody discovery

    FairJourney Bio has opened a cryo-EM structural biology facility in [...]

    April 17, 2026
  • Artificial Intelligence,Drug discovery,Research & Development,Technology and platforms

    Chemify founder publishes three papers on programmable chemistry and automated drug discovery

    Chemify founder Lee Cronin has published three peer-reviewed papers outlining [...]

    April 10, 2026
  • Artificial Intelligence,Drug discovery,Funding,Technology and platforms

    DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development

    DeepCyte, a techbio company developing AI-driven toxicology tools for drug [...]

    April 9, 2026
  • Artificial Intelligence,Drug Development,Drug discovery,Research & Development,Technology and platforms

    William Blair highlights Carterra as key player in AI-driven drug discovery shift

    A new analyst report from William Blair has highlighted Carterra [...]

    April 9, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top